|
gptkbp:instance_of
|
gptkb:Oncology
|
|
gptkbp:associated_with
|
gptkb:Epstein-Barr_virus
|
|
gptkbp:caused_by
|
abnormal lymphocytes
|
|
gptkbp:clinical_trial
|
ongoing research for new therapies
|
|
gptkbp:complication
|
lung damage
heart disease
secondary cancers
fertility issues
|
|
gptkbp:death
|
approximately 65% for advanced-stage
approximately 85% for early-stage
|
|
gptkbp:diagnosis
|
CT scan
biopsy
PET scan
|
|
gptkbp:events
|
regular check-ups
monitoring for recurrence
managing long-term effects
|
|
gptkbp:famous_person
|
gptkb:Tom_Brokaw
gptkb:Maggie_Smith
gptkb:Mickey_Mantle
gptkb:Ruth_Bader_Ginsburg
gptkb:Michael_C._Hall
|
|
gptkbp:first_described_by
|
gptkb:Thomas_Hodgkin
|
|
gptkbp:genetic_association
|
chromosome 14 abnormalities
chromosome 2 abnormalities
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Hodgkin's lymphoma
|
|
gptkbp:is_common_in
|
young adults
people aged 15 to 40
people over 55
|
|
gptkbp:is_involved_in
|
gptkb:Lymphoma_Coalition
gptkb:Lymphoma_Research_Foundation
gptkb:National_Institutes_of_Health
gptkb:Cancer_Support_Community
|
|
gptkbp:prevalence
|
approximately 2.5 cases per 100,000 people
|
|
gptkbp:public_awareness
|
September
|
|
gptkbp:risk_factor
|
age
family history
gender
weakened immune system
|
|
gptkbp:scientific_classification
|
gptkb:nodular_lymphocyte-predominant_Hodgkin_lymphoma
gptkb:classical_Hodgkin_lymphoma
|
|
gptkbp:symptoms
|
weight loss
fever
night sweats
swollen lymph nodes
|
|
gptkbp:treatment
|
gptkb:immunotherapy
radiation therapy
varies by individual
chemotherapy
targeted therapy
stem cell transplant
|
|
gptkbp:bfsParent
|
gptkb:Thomas_Hodgkin
gptkb:Ethan_Zohn
|
|
gptkbp:bfsLayer
|
6
|